<DOC>
	<DOCNO>NCT01810627</DOCNO>
	<brief_summary>This non-randomized study evaluate utility MVCT quality assurance measure patient treat interstitial permanent seed implant low intermediate risk prostate cancer . All patient receive standard care treatment receive additinoal CT image prostate .</brief_summary>
	<brief_title>Application Megavoltage Imaging Reduce Artifact After Seed Implants</brief_title>
	<detailed_description />
	<criteria>Male 5080 year age Eligible interstitial brachytherapy implant</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Prostate</keyword>
	<keyword>Cancer</keyword>
</DOC>